Wolverine Healing Protocol
Accelerate healing of tendons, ligaments, muscles, and joint injuries
Peptide Stack
Preparation
Reconstitute BPC-157 and TB-500 with bacteriostatic water. Add 2-3 ml slowly down the side of the vial. Gently swirl, do not shake. Store reconstituted peptides at 2-8°C (refrigerator) and use within 2-4 weeks.
Administration
Administer BPC-157 subcutaneously near the injury site twice daily (morning and evening). TB-500 should be injected subcutaneously or intramuscularly twice per week (Monday and Thursday), rotating injection sites. Maintain consistent timing for optimal results.
Monitoring
Track pain levels (0-10 scale), range of motion, swelling, and functional capacity weekly. Most users report noticeable improvements within 7-14 days. Continue for minimum 8 weeks. Consider ultrasound or MRI imaging at 4-week intervals for objective assessment.
Expected Timeline
Week 1-2: Reduced inflammation and pain (20-30% improvement). Week 3-4: Improved mobility and range of motion. Week 5-8: Continued tissue remodelling, strength gains, and return to full activity. Recovery typically 30-50% faster than natural healing.
Research Basis
BPC-157 has over 100 animal studies demonstrating accelerated healing of tendons, ligaments, and muscles. TB-500 (Thymosin Beta-4) has shown efficacy in Phase 2 clinical trials for wound healing. The combination provides complementary mechanisms: angiogenesis (BPC-157) and cell migration (TB-500).
Safety Considerations
- Do not use if you have active cancer due to angiogenic properties
- Avoid during pregnancy or breastfeeding
- Monitor injection sites for signs of infection
- Consult with a healthcare professional before starting
- UK residents should source peptides from reputable research suppliers
- This protocol is for research and educational purposes only
Protocol Overview
The gold standard healing protocol combining BPC-157 and TB-500. Designed for tendon, ligament, muscle, and joint injuries. Starts with a loading phase for rapid tissue repair, then maintains with lower doses.
Duration: 8 weeks Peptides: 2 Experience Level: Beginner
Peptide Stack
BPC-157
- Dose: 250-500 mcg
- Frequency: twice daily
- Timing: morning and evening
TB-500
- Dose: 2-5 mg
- Frequency: twice weekly
- Timing: Monday and Thursday
Preparation
Reconstitute BPC-157 and TB-500 with bacteriostatic water. Add 2-3 ml slowly down the side of the vial. Gently swirl, do not shake. Store reconstituted peptides at 2-8°C (refrigerator) and use within 2-4 weeks.
Administration
Administer BPC-157 subcutaneously near the injury site twice daily (morning and evening). TB-500 should be injected subcutaneously or intramuscularly twice per week (Monday and Thursday), rotating injection sites. Maintain consistent timing for optimal results.
Monitoring
Track pain levels (0-10 scale), range of motion, swelling, and functional capacity weekly. Most users report noticeable improvements within 7-14 days. Continue for minimum 8 weeks. Consider ultrasound or MRI imaging at 4-week intervals for objective assessment.
Expected Timeline
Week 1-2: Reduced inflammation and pain (20-30% improvement). Week 3-4: Improved mobility and range of motion. Week 5-8: Continued tissue remodelling, strength gains, and return to full activity. Recovery typically 30-50% faster than natural healing.
Research Basis
BPC-157 has over 100 animal studies demonstrating accelerated healing of tendons, ligaments, and muscles. TB-500 (Thymosin Beta-4) has shown efficacy in Phase 2 clinical trials for wound healing. The combination provides complementary mechanisms: angiogenesis (BPC-157) and cell migration (TB-500).
Safety Considerations
- Do not use if you have active cancer due to angiogenic properties
- Avoid during pregnancy or breastfeeding
- Monitor injection sites for signs of infection
- Consult with a healthcare professional before starting
- UK residents should source peptides from reputable research suppliers
- This protocol is for research and educational purposes only
Disclaimer: This protocol is for educational and research purposes only. It is not medical advice. Consult with a qualified healthcare professional before starting any peptide protocol. These compounds are not approved by the MHRA for human therapeutic use.
Important Disclaimer: This protocol is for educational and research purposes only. It is not medical advice. Consult with a qualified healthcare professional before starting any peptide protocol. These compounds are not approved by the MHRA for human therapeutic use.